RBX1 and plasma cell myeloma: RBX1, an E3 ubiquitin ligase activator, reportedly promoted cell cycle progression in melanoma and multiple myeloma cell lines, since lentiviral vector‐mediated overexpression enhanced progression into the S phase [22].